IN2013MU03373A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03373A
IN2013MU03373A IN3373MU2013A IN2013MU03373A IN 2013MU03373 A IN2013MU03373 A IN 2013MU03373A IN 3373MU2013 A IN3373MU2013 A IN 3373MU2013A IN 2013MU03373 A IN2013MU03373 A IN 2013MU03373A
Authority
IN
India
Prior art keywords
compositions
budesonide
controlled release
relates
processes
Prior art date
Application number
Inventor
Sushrut Krishnaji Kulkarni
Ajaykumar Handa
Pushpendra Pratap Singh
Ankur Paresh Shah
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN3373MU2013 priority Critical patent/IN2013MU03373A/en
Priority to US14/520,634 priority patent/US20150118296A1/en
Publication of IN2013MU03373A publication Critical patent/IN2013MU03373A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

ABSTRACT CONTROLLED RELEASE BUDESONIDE COMPOSITIONS The present invention relates to controlled release pharmaceutical compositions comprising budesonide. The invention also relates to processes for the preparation of such compositions and using those compositions in the treatment of Inflammatory Bowel Disease and Irritable Bowel Syndrome including mild to moderate ulcerative colitis.
IN3373MU2013 2013-10-25 2013-10-25 IN2013MU03373A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN3373MU2013 IN2013MU03373A (en) 2013-10-25 2013-10-25
US14/520,634 US20150118296A1 (en) 2013-10-25 2014-10-22 Controlled release budesonide compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3373MU2013 IN2013MU03373A (en) 2013-10-25 2013-10-25

Publications (1)

Publication Number Publication Date
IN2013MU03373A true IN2013MU03373A (en) 2015-07-17

Family

ID=52995730

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3373MU2013 IN2013MU03373A (en) 2013-10-25 2013-10-25

Country Status (2)

Country Link
US (1) US20150118296A1 (en)
IN (1) IN2013MU03373A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9707182B2 (en) 2015-09-11 2017-07-18 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical dosage forms of budesonide
CN109999201B (en) * 2019-04-19 2023-02-17 成都中医药大学 A kind of taste-masking companion agent and its application
CN110507627B (en) * 2019-09-29 2021-11-02 重庆医药高等专科学校 A kind of oral controlled-release pharmaceutical composition of budesonide
US11013748B2 (en) * 2019-10-03 2021-05-25 University of Nizwa Budesonide prodrug
CN110585164A (en) * 2019-10-08 2019-12-20 苏州弘森药业股份有限公司 Method for preparing esomeprazole magnesium sodium bicarbonate capsule
EP4346858A4 (en) * 2021-06-01 2025-06-18 NBI Biosciences Pvt Ltd Microbial-triggered oral intestinal drug delivery formulation and method of preparation thereof
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions
WO2025002033A1 (en) * 2023-06-26 2025-01-02 湖南慧泽生物医药科技有限公司 Corticosteroid-containing pharmaceutical composition and preparation method therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551632B2 (en) * 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
EP1183014B1 (en) * 1999-06-14 2003-10-08 Cosmo S.p.A. Controlled release and taste masking oral pharmaceutical compositions
US8895064B2 (en) * 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets

Also Published As

Publication number Publication date
US20150118296A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
IN2013MU03373A (en)
PL3349783T3 (en) Compositions and methods relating to the treatment of diseases
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
TW201613901A (en) New compounds
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
MX2017001971A (en) Anti-methanogenic compositions and uses thereof.
MX2021011906A (en) Delayed release compositions of linaclotide.
IN2014MN02049A (en)
IN2015MN00478A (en)
MD20170048A2 (en) Abiraterone acetate formulation and methods of use
PL3240550T3 (en) Combination of glycosaminoglycans and an antacid agent and compositions thereof
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX2016006975A (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases.
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
IN2013MU03641A (en)
IN2014DN06662A (en)
MX2015013755A (en) Pharmaceutical formulation for use in the treatment and/or prevention of restenosis.
MX2015001648A (en) Compositions comprising spicamycin derivatives and methods of use thereof.
MY182818A (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
GB2527233A (en) Composition comprising hydrocortisone
PL3079684T3 (en) Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
IN2013MU03317A (en)
PH12017501693A1 (en) Compositions for the treatment of kidney and/or liver diseases
IL255247A0 (en) Pharmaceutical formulation for the treatment of inflammatory changes to the rectum
WO2016083315A8 (en) Use of ox1r antagonists for the treatment of inflammatory bowel diseases